Y. Adachi et al., LIPOPOLYSACCHARIDE INCREASES FIBRONECTIN PRODUCTION AND RELEASE FROM CULTURED LUNG FIBROBLASTS PARTIALLY THROUGH PROTEOLYTIC ACTIVITY, The Journal of laboratory and clinical medicine, 127(5), 1996, pp. 448-455
Citations number
20
Categorie Soggetti
Medical Laboratory Technology","Medicine, General & Internal
Fibronectin is a major product of fibroblasts and can mediate diverse
functions including wound healing. Chronic bacterial infections are ge
nerally associated with a marked decrease in the ability to repair. We
therefore hypothesized that bacterial endotoxin, lipopolysaccharide (
LPS), might alter fibroblast fibronectin production. LPS augmented fib
ronectin production by fibroblasts and also stimulated the release of
fibronectin from cell layers. An increase in new protein synthesis app
eared to account for part of the increased fibronectin, because the in
hibitor of protein synthesis, cycloheximide, inhibited the increase in
total production of fibronectin. Cycloheximide did not attenuate the
increased release of fibronectin into the culture medium. This increas
ed release appealed to be caused, at least in part, by fragmentation o
f fibronectin by proteases contained in LPS preparations. In this rega
rd all preparations of LPS tested were found to cleave fibronectin. Fi
nally, zymograms indicated that LPS could also cleave gelatin with at
least two bands of proteolytic activity but that it did not cleave bov
ine serum albumin or ovalbumin. These results indicate that the abilit
y of bacterial products to alter fibronectin production and to degrade
this macromolecule may account for altered wound repair that occurs w
ith chronic bacterial infection.